This PubMed entry describes a study titled "Assessing the Feasibility of a Self-Management Intervention for Individuals With Advanced Prostate Cancer and Comorbid Type II Diabetes Mellitus." The article focuses on the feasibility of a self-management intervention designed for people living with advanced prostate cancer who also have type II diabetes mellitus. The PubMed record indicates the study was published in Cancer Medicine in August 2026 (15[8]:e72046).
The article lists Amy L. Shaver as the first author, with a multi-author team including Christina Steinbock-Malfer, William Tester, Patrick Mille, William K. Kelly, Kevin K. Zarrabi, Costas D. Lallas, Mihir Shah, Rose DiMarco, Emily Brand, Shawntel Brown, Swapnil Sharma, Nikita Nikita, Cindy Cogen, Scott W. Keith, and Grace Lu-Yao. Affiliations reported on the PubMed page include the Division of Population Science, Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, and the Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. A Division of Biostatistics and Bioinformatics within the Department of Pharmacology, Physiology, and Cancer Biology at the same institution is also listed among affiliations.
The PubMed record provides the bibliographic citation Cancer Med. 2026 Aug;15(8):e72046 and identifies the publication as a randomized controlled trial. Indexing information includes PMID 42521319, PMCID PMC13413227, and DOI 10.1002/cam4.72046. The PubMed page supplies links to full-text options, including the Wiley publisher link.
The PubMed entry explicitly categorizes the work as a Randomized Controlled Trial and frames the study aim as assessing the feasibility of a targeted self-management program for patients with concurrent advanced prostate cancer and type II diabetes mellitus. Feasibility studies commonly address recruitment, retention, acceptability, adherence, and preliminary signals of efficacy; however, the specific feasibility domains evaluated in this trial are not described in the extracted source content.
The source labels the article a randomized controlled trial and provides the standard bibliographic and indexing metadata expected for such a report. Beyond the trial type designation, no numeric or outcome data, no descriptions of randomization procedures, no timing or follow-up intervals, and no statistical results are available in the provided text.
The PubMed record includes a DOI (10.1002/cam4.72046) and provides a PMCID (PMC13413227), indicating the article is available in PubMed Central. A Wiley full-text link is listed on the page. These identifiers and links should enable readers to retrieve the complete article for methodological details and full results.
The provided PubMed excerpt does not include the study abstract or substantive content such as: participant eligibility criteria, sample size and recruitment numbers, randomization method, detailed description of the self-management intervention, control or comparator condition, outcome measures, feasibility thresholds or endpoints, safety data, numerical results, statistical analyses, or the authors’ conclusions. Conflict of interest statements, figures, references, MeSH terms, and grant/funding details are referenced by the page but were not included in the available content.
When key trial information is absent from an extracted record, it is not appropriate to infer outcomes, effect sizes, or feasibility conclusions. Any such details must be obtained from the full text.
The PubMed record supplies direct links to full-text resources, including a Wiley link and a PMCID indicating availability via PubMed Central. For complete methods, participant characteristics, intervention components, feasibility measures, results, and authors’ interpretations, consult the full-text article using the DOI 10.1002/cam4.72046, PMCID PMC13413227, or the publisher link provided on the PubMed page.
This record documents a peer-reviewed randomized controlled feasibility trial addressing an important clinical intersection: management of advanced prostate cancer in the context of comorbid type II diabetes mellitus. The PubMed metadata (authors, affiliations, journal citation, DOI, PMID, PMCID) and the trial designation are provided in the source content. Specific trial methods, outcomes, and conclusions were not present in the supplied text and therefore are not reported here. Readers seeking actionable clinical detail or evidence to inform practice should review the full article via the provided DOI or PMCID to evaluate the intervention components, feasibility outcomes, and any preliminary efficacy or safety data reported by the authors.